Video Overview: BioScience Day at the Colorado Capitol 2014

BioScience Day at the Capitol was held January 23rd, in the Old Supreme Court Chambers. The event featured U.S. Senator Mark Udall providing a federal policy update; a Women in BioScience Executive Panel discussion; and Patient Impact Testimonials, in addition to a full overview of the legislative and policy items. If you were unable to attend the Bioscience Day at the Capitol, CBSA's State Policy Priorities publication can be found at: http://www.cobioscience.com/advocacy/Policy%20Priorities%202014.final.pdf

April Giles: The Impact of BioScience

http://youtu.be/D95WUqOXikE

Colorado Senator John Kefalas: Welcome Remarks

http://youtu.be/oAPIRMcNJg8 

Colorado Representative Cheri Gerou: Welcome Remarks
http://youtu.be/lbEhmBKV3nU

Scott Larsen: CBSA Policy Update
http://youtu.be/jrJIuYFgxk4

AlloSource: Patient Impact Testimonial
http://youtu.be/-y1U7_AkEkY

Women In BioScience: Executive Panel
http://youtu.be/k0a4JCqgC_E

Carrie Hatrgren: About AdvaMed
http://youtu.be/cvCTKl-k3Pc

Colorado State Representative Dickey Lee Hullinghorst: Welcome Remarks
http://youtu.be/IIzSUzxFkBk

Colorado State Representative Frank McNulty: Welcome Remarks
http://youtu.be/fHudmmgT3a8

U.S. Senator Mark Udall: Federal Update
http://youtu.be/13gJZrz0C2M

#UnitedInOrange Tabbies Adoption Special at Cat Care Society

In support of the Denver Broncos and in honor of Super Bowl 48, Cat Care Society is putting its First String of Tabby Cats up for adoption for $48 per "player." Adoption fees include required shots, a mini-catnip football, a uniform/bandana and Perpet-U-Care for our veteran/senior cat players (to help pay for veterinary care at The Cat Clinic at Cat Care Society).

Note: An anonymous donor has pledged a $100.00 contribution to CCS for every tabby adopted during this Super Bowl XLVIII adoption special.

The Cat Care Society Shelter, located near 6th Avenue and Sheridan on the Frontage Road at 5787 W. 6th Avenue, is open: Tuesday through Friday Noon - 5:30 p.m.; Saturday 11 a.m. - 4:30 p.m.; Sunday Noon – 3 p.m.; and is closed Mondays. Please come early if you plan to adopt, since adoptions end 45 minutes prior to close of business, due to the necessary paperwork that needs to be processed.

The #UnitedInOrange Tabbies Adoption Special lasts through Super Bowl Sunday, February 2, and will be extended through February 28th if the Broncos win.

Here's the lineup:

Great News! 
Andrew Omaha was adopted 1/25 to his Forever Home under this special.
00 Andrew 'Omaha' - link to Andrew's profile

18 Jasper 'Peyton Manning' (eligible for Perpet-U-Care)- link to Jasper's profile

24 Paisley 'Champ Bailey' (eligible for Perpet-U-Care)- link to Paisley's profile

27 Ginger 'Knowshon Moreno' - link to Ginger's profile

87 PJ 'Eric Decker' - link to PJ's profile

94 Barney 'Pot Roast Knighton' (eligible for Perpet-U-Care)- link to Barney's profile







View the slideshow:

http://youtu.be/Ma8KC0cGkM4

BioScience Day at the Colorado Capitol: CBSA Hosts U.S. Senator Mark Udall and Announces New Legislation

Colorado BioScience Association (CBSA) will host the sixth annual “BioScience Day at the Capitol” on Thursday, January 23rd, 7:30-11:00 a.m. at the Capitol Building in the Old Supreme Court Chambers (200 E. Colfax Ave., Denver, 80203). The event will feature U.S. Senator Mark Udall providing a federal policy update; a Women in BioScience Executive Panel discussion; and Patient Impact Testimonials.

This session, CBSA and Colorado Cleantech Industries Association (CCIA) are initiating the 2014 Colorado Advanced Industry Investment Income Tax Credit legislation to encourage private sector investment and create jobs for Colorado’s Advanced Industry Sectors. The legislation will provide a 25% (30% in rural or economically distressed areas of the state) income tax credit to qualified investors who invest more than $25,000 in a qualified advanced industry company beginning July, 2014-2018. The proposal expands and redefines HB 09-1105 and HB 11-1045, which established the Colorado Innovation Investment Tax Credit (2010 pilot program).

Agenda for BioScience Day at the Capitol: 

* CBSA Policy Update
* Patient Impact Testimonials
* Women in BioScience: Executive Panel
* Carrie Hartgen, AdvaMed
* U.S. Senator Mark Udall Federal Update
* Floor visit and meetings with legislators (attendees on own)

Link to register for the Jan 23rd event 
  
Link to the Business Wire release 
  
Link to the PitchEngine social media release

Business Xpansion Journal: 'Bioscience’s Bright Spots'

Quoting from the Jan 13th posting:

"Gaining prominence on the national stage in recent years is Colorado, which has grown nearly 600 medical device, diagnostic, pharmaceutical and ag-bio companies into a thriving bioscience cluster.

'Colorado has seen some good growth over the last 10 years and the state’s put in infrastructure and grant programs over the last four to five years that have been really helpful in creating momentum for all of our advanced industries, including bioscience,' says April Giles, president and CEO, Colorado BioScience Association. 'Over the last two years we’ve seen our medical device community grow in employment around 15 percent and the industry as a whole at 4.5 percent, with an uptick in biopharma, which has also been great.'

In addition to a highly-educated workforce and an active venture-capital market, one of the state’s prized industry assets is the Fitzsimons Life Science District and the adjacent University of Colorado’s Anschutz Medical Campus in Aurora. Together they form a 578-acre site dedicated to bioscience, biotechnology, health care, medical education and advanced research — making it the largest development of its kind in the state and one of the largest bioscience real estate developments in the country."
 
Link to the posting

Wall St Jrnl: 'Ampio Pharmaceuticals Breaks Ground on Construction of Ampion(TM) Manufacturing Facility'

Quoting from the January 15th posting:

"Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) held a groundbreaking ceremony on Friday, January 10th to announce the start of construction of its new state-of-the-art manufacturing facility for its lead drug candidate, Ampion (TM), for the treatment of patients afflicted with osteoarthritis of the knee. Located in the Denver Metro area, the facility is expected to be ready for production of Ampion (TM) in the summer of 2014 and should generate approximately 40 new jobs in the next two years...

...April Giles, President and CEO, Colorado BioScience Association remarked 'We congratulate Ampio Pharmaceuticals on their decision to locate their new manufacturing facility in the Denver Tech Center. Ampio Pharmaceutical's decision to grow their company in Colorado and to focus on innovative methods of treating patient's with debilitating medical conditions has served the company and the community well.'"

Link to wsj.com